Mbx Biosciences, Inc. Common Stock Stock Prediction and Forecast [MBX]

AI-generated source summary

The analysis assesses MBX Biosciences Inc. Common Stock. Since September 22, 2025, the system ranked the stock as "Hold/Accumulate" with a score of 0. The stock's shorter trend has broken through its ceiling, anticipating an increase in volatility. The longer-term, 3-month analysis projects a potential change of 2.32%, with returns ranging from -50.03% to -19.68%. The 12-month analysis suggests a -36.32% change. Based on these trends, a potential peak, per fan theory, is $21.63. The latest daily report shows a close at $20.00 with high volatility of 48.88%, increasing in volume. Signals indicate positive buy signals for both the short and long term, yet there is a general sell signal because the long-term average is above the short-term. The analysis recommends a stop-loss at $19.26, a 3.70% decline, and suggests holding/accumulating.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   23 Sept 2025, 04:06 UTC

   The analyst published the original source item.

2. First prediction resolved

   24 Sept 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   24 Sept 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:12 UTC

   Tahlil Plus began monitoring the extracted predictions.